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Abstract
Background
Gestational hypertensive diseases (GHD) and gestational diabetes mellitus (GDM) increase
the risk of cardiovascular disease (CVD) later in life. However, the association between ges-
tational medical diseases and familial history of CVD has not been investigated to date. In
the present study, we examined the association between familial history of CVD and GHD
or GDM via reliable questionnaires in a large cohort of registered nurses.
Methods
The Korean Nurses’ Survey was conducted through a web-based computer-assisted self-
interview, which was developed through consultation with cardiologists, gynecologists, and
statisticians. We enrolled a total of 9,989 female registered nurses who reliably answered
the questionnaires including family history of premature CVD (FHpCVD), hypertension
(FHH), and diabetes mellitus (FHDM) based on their medical knowledge. Either multivari-
able logistic regression analysis or generalized estimation equation was used to clarify the
effect of positive family histories on GHD and GDM in subjects or at each repeated preg-
nancy in an individual.
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Results
In this survey, 3,695 subjects had at least 1 pregnancy and 8,783 cumulative pregnancies.
Among them, 247 interviewees (6.3%) experienced GHD and 120 (3.1%) experienced
GDM. In a multivariable analysis adjusted for age, obstetric, and gynecologic variables, age
at the first pregnancy over 35 years (adjusted OR 1.61, 95% CI 1.02–2.43) and FHpCVD
(adjusted OR 1.60, 95% CI 1.16–2.22) were risk factors for GHD in individuals, whereas
FHH was not. FHDM and history of infertility therapy were risk factors for GDM in individuals
(adjusted OR 2.68, 95% CI 1.86–3.86; 1.84, 95% CI 1.05–3.23, respectively). In any
repeated pregnancies in an individual, age at the current pregnancy and at the first preg-
nancy, and FHpCVD were risk factors for GHD, while age at the current pregnancy, history
of infertility therapy, and FHDM were risk factors for GDM.
Conclusions
The FHpCVD and FHDM are significantly associated with GHD and GDM, respectively.
Meticulous family histories should be obtained, and women with family histories of these
conditions should be carefully monitored during pregnancy.
Background
Gestational diabetes mellitus (GDM) and gestational hypertensive disorders (GHD), compris-
ing preeclampsia and gestational hypertension, are common medical complications in preg-
nancy that result in high maternal mortality and morbidity and poorer pregnancy outcomes.
[1, 2] They are also well-known risk factors for cardiovascular disease (CVD) later in maternal
life.[3–9] However, it remains unclear whether GHD and GDM initiate vascular changes that
become clinically evident later or whether a pre-pregnancy predisposition to CVD increases
the risk of GHD and GDM. GHD and GDM may induce cardiovascular change by promoting
endothelial inflammation and early atherosclerosis, independent of underlying conditions.
[10–12] Conversely, GHD and GDM may be a result of inherent susceptibility to CVD includ-
ing genetic factors. Mothers who were obese or had a personal history of chronic hypertension
or diabetes before pregnancy were more likely to develop GHD or GDM.[13–15] Furthermore,
family history of cardiovascular risk factors has been well established to closely relate to the
occurrence of future CVD.[16, 17] To the best of our knowledge, no previous report have eval-
uated the association between gestational medical diseases and familial history of cardiovascu-
lar disease such as stroke, angina, or myocardial infarction. In the present study, we
investigated the association between familial history of cardiovascular disease and GHD or
GDM via reliable questionnaires in a large cohort of registered nurses.
Methods
Study population
The Korean Nurses’ Survey is a cross-sectional survey that was conducted through web-based
computer-assisted self-interview (CASI) from October to December 2011 for the purpose of
assessing the association between lifestyle and CVD in Korean women to identify targets for
preventive measures in this population. The Korean National Institute of Health performed
this survey in collaboration with the Korean Nurses Association and Seoul National University
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Bundang Hospital. The number of registered nurses in South Korea is estimated to be 250,000.
The Korean Nurses Association sent all registered nurses currently licensed to practice in
Korea e-mails containing a link to the web-based CASI and advertised the survey on its web
page, which also linked to the CASI. Among them, 10,000 nurses registered on the website,
and six who were younger than 20 years of age, one who was not identified in the nurse regis-
try, and four with incomplete responses were excluded from the study. We finalized the data-
base with a total of 9,989 female registered nurses, who reliably answered the questionnaires
based on their medical knowledge. Among them, 3,895 subjects with a history of at least one
pregnancy were included and analyzed in the present study (Fig 1). The study protocol was
approved by the Institutional Review Board of Seoul National University Bundang Hospital
(IRB No. B-1111-139-012). Electronic informed consent was obtained from all study partici-
pants which was approved by the IRB.
Questionnaires
The questionnaires had 175 questions that were compiled by cardiologists, gynecologists,
endocrinologists, and statisticians, and it collected information regarding demographic char-
acteristics; comorbidities; past medical history and current medications; family history of dis-
eases; obstetrical, social, psychiatric and occupational characteristics; and dietary patterns (S1
and S2 Files). Next, we developed a CASI system that produced a database at the same time as
an interviewee answered the questions on the web-based program. We included a function
that automatically skipped unnecessary questions to reduce the total response time for 175
questions, which was 19 min on average for the 100 pilot interviewees. The reliability and
validity of the questionnaire was tested in 100 subjects with offline interviews. We compared
Fig 1. Study flow.
doi:10.1371/journal.pone.0167528.g001
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the data including height, weight, and waist circumference from CASI system and offline
interviews. There was no significant difference between the data.
The questionnaire collected information including demographic data, underlying diseases,
cardiovascular symptoms, history of cardiovascular diseases, menarche, menstruation, meno-
pause, history of contraception, infertility therapy, smoking, exercise, and dietary records.
Family history of cardiovascular diseases and risk factors were also evaluated on the question-
naire. The family history included 1) whether first-degree blood relatives of the interviewee
had a premature cerebral or cardiac vascular disease (CVD), which was defined as CVD diag-
nosed before 55 years of age in men or 65 years of age in women[18], or whether first-degree
blood relatives of the interviewee had the following diseases at any age: 2) hypertension, 3) dys-
lipidemia, 3) diabetes mellitus, 4) stroke, 5) angina, or 6) myocardial infarction. Gestational
data were also obtained from the questionnaire, including the number of times an interviewee
became pregnant (gravidity), gave birth to a baby (parity), and the details of each pregnancy
(up to 5) including age at the pregnancy, duration, outcome, whether the interviewee experi-
enced GHD or GDM, delivery method, birth weight, breast feeding duration, and postpreg-
nancy weight gain.
Statistical analysis
Demographic and obstetric characteristics and familial cardiovascular risk factors were com-
pared according to interviewees’ experience of GHD or GDM. Continuous variables are
expressed as mean ± standard deviation (SD), whereas categorical variables are presented as
absolute values and proportions. Differences between continuous variables were compared
using the Student t test for independent samples, and differences between categorical variables
were compared using the χ2 test or Fisher exact test, as appropriate. Multivariable logistic
regression analysis was conducted to assess the association between family history of cardio-
vascular risk factors and gestational medical diseases and expressed with an odds ratio (OR)
and corresponding 95% confidence interval (CI) after adjusting for potential confounders. We
also analyzed the associations at each pregnancy, which included multiple pregnancies of a
subject using generalized estimating equations because every pregnancy had potential con-
founding factors including age at the pregnancy and the order of pregnancy (primi-para vs.
multi-para). A value of p<0.05 was considered to indicate statistical significance. All analyses
were performed using SPSS 21.0 statistical software (SPSS Inc., IBM Co., Chicago, IL, USA).
Results
Baseline demographic, obstetric, and gynecologic characteristics
In the Korea Nurses’ Survey, a total of 3,895 study participants (age 40.3 ± 8.0 years; age at the
1st pregnancy 28.6 ± 3.2 years) had at least one pregnancy, cumulatively reporting a total of
8,783 pregnancies and 6,685 parities (Table 1). Among them, 247 interviewees (6.3%)
responded that they had experienced GHD in at least one pregnancy, which included pre-
eclampsia (n = 120, 3.1%) and transient hypertension (n = 127, 3.2%), and 120 (3.1%)
responded that they had experienced GDM in at least one pregnancy. Interviewees with a his-
tory of GHD had higher BMI at the time of survey completion, whereas those with a history of
GDM did not. Gravidity and parity were not different between the no-GHD and GHD groups
or the no-GDM and GDM groups (Fig 2). Those with GHD or GDM were older at the first
pregnancy as well as at the first parity. The age distribution and average age at each pregnancy
among the 8,783 cumulative pregnancies did not differ between pregnancies involving GHD
and other pregnancies (Fig 3A). However, the average age at pregnancies involving GDM was
higher than of pregnancies without GDM (Fig 3B). The prevalence of GHD gradually
Yoon Familial CVD and Gestational Medical Disease Risk
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decreased with progressive pregnancies, whereas GDM prevalence did not differ according to
the order of pregnancies (Fig 3C and 3D).
Among 247 patients with GHD, 35 had at least two events of GHD in sequential pregnan-
cies. Among 120 patients with GDM, 21 had at least two events of GDM in sequential
Table 1. Baseline characteristics of the study population.
Total (n = 3,895) GHD (+) (n = 247) GHD (-) (n = 3,648) p GDM (+) (n = 120) GDM (-) (n = 3775) p
Age at the survey (years) 40.3 ± 8.0 40.9 ± 7.9 40.3 ± 8.0 0.241 39.9 ± 6.5 40.4 ± 8.0 0.467
BMI (kg/m2) at the survey 21.8 ± 2.7 22.4 ± 2.5 21.8 ± 2.5 < 0.001 22.1 ± 2.4 21.9 ± 2.6 0.299
Age at first pregnancy 28.6 ± 3.2 29.0 ± 3.1 28.6 ± 3.3 0.046 29.3 ± 2.9 28.6 ± 3.3 0.032
Age at first parity 28.5 ± 3.1 29.4 ± 3.0 28.9 ± 3.0 0.052 29.6 ± 2.9 29.0 ± 3.0 0.025
Age at first event 30.0 ± 3.3 31.1 ± 3.2
Menarche 12years 598 (15.4%) 42 (17%) 556 (15.2%) 0.465 19 (15.8%) 579 (15.3%) 0.898
Menstrual regularity (<4 days) 2492 (64%) 167 (67.6%) 2325 (63.7%) 0.244 67 (55.8%) 2425 (64.2%) 0.066
Menstrual cycle (<30 days) 3015 (77.4%) 201 (81.4%) 2814 (77.1%) 0.135 82 (68.3%) 2933 (77.7%) 0.020
Use of oral contraceptive pill 355 (9.6%) 26 (9.6%) 329 (9.6%) 0.956 12 (10.0%) 361(9.6%) 0.873
Infertility therapy 295 (7.6%) 22 (8.9%) 273 (7.5%) 0.778 15 (12.5%) 280 (7.4%) 0.038
GHD = gestational hypertensive disease; GDM = gestational diabetes mellitus; BMI = body mass index.
doi:10.1371/journal.pone.0167528.t001
Fig 2. Gravidity and parity of the study subjects. (A) Histogram of the number of gravidity in subjects with GHD or no GHD. (B) Histogram of the
number of gravidity in subjects with GDM or no GDM. (C) Histogram of the number of parity in subjects with GHD or no GHD. (D) Histogram of the number
of parity in subjects with GDM or no GDM.
doi:10.1371/journal.pone.0167528.g002
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pregnancies. The distributions of the initial occurrence of GHD or GDM and their recurrence
according to the order of pregnancy are shown in Fig 4. The rates of GHD or GDM recurrence
at the subsequent pregnancy in the subjects who experienced GHD or GDM at the previous
pregnancy were 22.3% (23 of 103) and 33.3% (13 of 39), respectively. The GDM group
reported more frequent menstrual irregularity and longer menstrual cycles and had a higher
rate of infertility therapy than the no-GDM group (Table 1). Twenty-five interviewees (0.6%)
responded that they had experienced both GHD and GDM. Twenty-two patients experienced
both GHD and GDM in the same pregnancy. Their characteristics were not noticeable com-
pared to those with GHD or GDM (S1 Table).
Familial history of cardiovascular risk factors and diseases
The familial history of CVD had different patterns in the GHD and GDM groups (Table 2).
Subjects with GHD had more frequent positive familial histories of premature CVD
(FHpCVD), hypertension (FHH), dyslipidemia, and stroke than those without GHD. How-
ever, those with GDM showed more frequent familial history of DM (FHDM) and angina
Fig 3. Distribution of age at every repeated pregnancy and frequency of GHD or GDM according to the order of pregnancy. (A) Histogram of age
at the pregnancy in subjects with GHD or no GHD. (B) Histogram of age at the pregnancy in subjects with GDM or no GDM. (C) Incidence of GHD
according to the order of pregnancy. (D) Incidence of GDM according to the order of pregnancy.
doi:10.1371/journal.pone.0167528.g003
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pectoris. The detailed prevalence of familial history of cardiovascular risk factors and diseases
is shown in Table 2.
The association of familial history of cardiovascular risk factors and
diseases and the occurrence of GHD or GDM in subjects
Among demographic, obstetric, and gynecologic variables, the occurrence of GHD in an
individual was closely related to age at the first pregnancy 35 years and family history of
premature CVD, hypertension, dyslipidemia, or stroke in univariable analyses (Table 3). In
multivariable analysis, adjusting for the significant variables in univariable analyses as well as
obstetric and gynecologic variables, age and FHpCVD were associated with the occurrence of
GHD in a subject (adjusted OR [95% CI] 1.61 [1.02–2.43]; 1.60 [1.16–2.22], respectively). The
occurrence of GDM was associated with a longer menstrual cycle (>30 days), history of
Fig 4. Distribution of the occurrence of GHD or GDM according to the order of pregnancy. (A) The x-axis denotes the order of pregnancy. The y-
axis indicates the arbitrary numbers of subjects. Every number matches each patient with GHD. To better demonstrate the distribution of the occurrence of
GHD, subjects with more occurrences and subjects with earlier occurrence were placed at lower arbitrary numbers. (B) A magnified graph from the
dashed-line rectangle in (A). (C), (D) Similarly, distribution of the occurrence of GDM according to the order of pregnancy.
doi:10.1371/journal.pone.0167528.g004
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previous infertility therapy, FHDM, and family history of angina pectoris in univariable analy-
ses. In multivariable analysis, history of previous infertility therapy, FHDM, and family history
of angina were risk factors for the occurrence of GDM in a subject (adjusted OR 2.68, 95% CI
1.86–3.86; 1.79, 95% CI 1.00–3.01).
Table 2. Familial history of cardiovascular risk factors and diseases.
Total (n = 3,895) GHD (+) (n = 247) GHD (-) (n = 3,648) p GDM (+) (n = 120) GDM (-) (n = 3775) p
Premature CVD* 955 (24.5%) 85 (34.4%) 870 (23.8%) < 0.001 37 (30.8%) 918 (24.3%) 0.106
Hypertension 2,245 (57.6%) 161 (65.2%) 2,084 (57.1%) 0.014 75 (62.5%) 2,170 (57.5%) 0.302
Diabetes mellitus 1,138 (29.2%) 75 (30.4%) 1,063 (29.1%) 0.665 62 (51.7%) 1,076 (28.5%) < 0.001
Dyslipidemia 1,226 (31.5%) 92 (37.2%) 1,134 (31.1%) 0.047 46 (38.3%) 1,180 (31.3%) 0.110
Stroke 608 (15.6%) 55 (22.3%) 553 (15.2%) 0.005 24 (20.0%) 584 (15.5%) 0.200
Angina pectoris 352 (9.0%) 23 (9.3%) 329 (9.0%) 0.819 19 (15.8%) 333 (8.8%) 0.014
Myocardial infarction 193 (5.0%) 12 (4.9%) 181 (5.0%) 0.942 4 (7.3%) 189 (4.6%) 0.524
* Premature CVD was defined as CVD diagnosed before 55 years of age in men or 65 years of age in women.
CVD = cardiovascular disease; GHD = gestational hypertensive disease; GDM = gestational diabetes mellitus.
doi:10.1371/journal.pone.0167528.t002
Table 3. Univariable and multivariable analysis of risk factors for GHD or GDM in subjects.
A. GHD Unadjusted OR (95% CI) Adjusted OR* (95% CI)
Age at first pregnancy 35 years 1.63 (1.04–2.45) 1.61 (1.02–2.43)
Familial history of
Premature CVD 1.68 (1.27–2.20) 1.60 (1.16–2.22)
Hypertension 1.40 (1.07–1.84)
Diabetes mellitus 1.06 (0.80–1.40)
Dyslipidemia 1.32 (1.01–1.72)
Stroke 1.60 (1.16–2.18)
Angina pectoris 1.04 (0.67–1.62)
Myocardial infarction 0.98 (0.54–1.78)
B. GDM Unadjusted OR (95% CI) Adjusted OR* (95% CI)
Age at first pregnancy 35 years 1.43 (0.74–2.53)
Menstrual regularity (<4 days) 0.70 (0.49–1.02)
Menstrual cycle (<30 days) 0.62 (0.42–0.93)
Infertility therapy 1.78 (1.02–3.11) 1.84 (1.05–3.23)
Familial history of
Premature CVD 1.39 (0.94–2.06)
Hypertension 1.23 (0.85–1.79)
Diabetes mellitus 2.68 (1.86–3.86) 2.68 (1.86–3.86)
Dyslipidemia 1.37 (0.94–1.99)
Stroke 1.37 (0.87–2.16)
Angina pectoris 1.94 (1.18–3.22) 1.79 (1.00–3.01)
Myocardial infarction 0.65 (0.24–1.79)
* Adjusted by age at first pregnancy 35 years, menarche 12 years, menstrual regularity (<4 days), menstrual cycle (<30 days), history of infertility
therapy, history of oral contraceptive pill, familial history of premature CVD, hypertension, diabetes mellitus, dyslipidemia, stroke, angina pectoris, and
myocardial infarction.
CVD = cardiovascular disease; GHD = gestational hypertensive disease; GDM = gestational diabetes mellitus; OR = odds ratio.
doi:10.1371/journal.pone.0167528.t003
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The association of familial history of cardiovascular risk factors and
diseases and the occurrence of GHD or GDM at the first pregnancy
ending in delivery in subjects
The first pregnancy ending in delivery is a higher-risk pregnancy involving more frequent
pregnancy-related complications including GHD and GDM. Therefore, the impact of familial
history on the occurrence of GHD and GDM at the first pregnancy ending in delivery is of par-
ticular interest. The occurrence of GHD at the first pregnancy ending in delivery was closely
related to age at the pregnancy, FHpCVD, FHH, and family history of stroke in univariable
analyses (Table 4). In multivariable analysis, age at the pregnancy and FHpCVD were risk fac-
tors for the occurrence of GHD in a subject (adjusted OR [95% CI] 1.09 [1.03–1.16]; 1.60
[1.00–2.52], respectively]. The occurrence of GDM was significantly associated with history of
previous infertility therapy, FHDM, and family history of dyslipidemia in univariable analyses.
In multivariable analysis, age at the pregnancy and FHDM were risk factors for the occurrence
of GDM at the first pregnancy ending in delivery (adjusted OR 1.12, 95% CI 1.04–1.20; 2.94,
95% CI 1.81–4.80).
Table 4. Univariable and multivariable analysis of risk factors for GHD or GDM at the first parity in
subjects.
A. GHD Unadjusted OR (95% CI) Adjusted OR* (95% CI)
Age at the pregnancy (y) 1.10 (1.03–1.16) 1.09 (1.03–1.16)
Familial history of
Premature CVD 1.67 (1.13–2.45) 1.60 (1.00–2.52)
Hypertension 1.47 (1.00–2.19)
Diabetes mellitus 1.03 (0.68–1.52)
Dyslipidemia 1.32 (0.90–1.92)
Stroke 1.77 (1.14–2.69)
Angina pectoris 0.64 (0.27–1.28)
Myocardial infarction 0.68 (0.21–1.65)
B. GDM Unadjusted OR (95% CI) Adjusted OR* (95% CI)
Age at the pregnancy (y) 1.13 (1.05–1.21) 1.12 (1.04–1.20)
Menstrual regularity (<4 days) 0.71 (0.45–1.13)
Menstrual cycle (<30 days) 0.64 (0.39–1.06)
Infertility therapy 2.47 (1.32–4.64)
Familial history of
Premature CVD 0.97 (0.55–1.63)
Hypertension 1.14 (0.72–1.84)
Diabetes mellitus 2.90 (1.83–4.62) 2.94 (1.81–4.80)
Dyslipidemia 1.66 (1.03–2.62)
Stroke 1.01 (0.52–1.82)
Angina pectoris 0.89 (0.34–1.90)
Myocardial infarction 0.26 (0.01–1.19)
* Adjusted by age at the first parity, menarche 12 years, menstrual regularity (<4 days), menstrual cycle
(<30 days), history of infertility therapy, history of oral contraceptive pill, familial history of premature CVD,
hypertension, diabetes mellitus, dyslipidemia, stroke, angina pectoris, and myocardial infarction
CVD = cardiovascular disease; GHD = gestational hypertensive disease; GDM = gestational diabetes
mellitus; OR = odds ratio.
doi:10.1371/journal.pone.0167528.t004
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Univariable and multivariable analysis of risk factors for GHD or GDM at
each repeated pregnancy
We further investigated risk factors for the occurrence of GHD or GDM at each pregnancy
including analysis of repeated pregnancies (Table 5). Compared to the first pregnancy, the risk
of GHD gradually decreased as the order of pregnancy increased. There was no demographic,
obstetric, or gynecologic variable that affected the occurrence of GHD at each pregnancy.
Table 5. Univariable and multivariable analysis of risk factors for GHD or GDM at each pregnancy
(total 8,783 pregnancies).
A. GHD Unadjusted OR (95% CI) Adjusted OR* (95% CI)
Age at the pregnancy (y) 1.01 (0.98–1.03) 1.06 (1.02–1.09)
The order of pregnancy compared to the first one
Second pregnancy 0.62 (0.48–0.80) 0.53 (0.40–0.69)
Third pregnancy 0.56 (0.39–0.81) 0.43 (0.28–0.65)
Fourth pregnancy 0.24 (0.11–0.54) 0.19 (0.09–0.43)
Fifth pregnancy 0.13 (0.02–0.96) 0.10 (0.01–0.43)
Familial history of
Premature CVD 1.56 (1.18–2.07) 1.56 (1.13–2.14)
Hypertension 1.34 (1.01–1.76)
Diabetes mellitus 0.98 (0.73–1.31)
Dyslipidemia 1.26 (0.96–1.66)
Stroke 1.39 (1.01–1.92)
Angina pectoris 1.06 (0.66–1.68)
Myocardial infarction 0.87 (0.47–1.62)
B. GDM Unadjusted OR (95% CI) Adjusted OR* (95% CI)
Age at the pregnancy 1.07 (1.03–1.10) 1.08 (1.03–1.12)
The order of pregnancy compared to the first one
Second pregnancy 1.03 (0.74–1.44)
Third pregnancy 1.02 (0.63–1.64)
Fourth pregnancy 0.66 (0.28–1.53)
Fifth pregnancy 1.88 (0.76–4.67)
Menstrual regularity (<4 days) 0.75 (0.51–1.11)
Menstrual cycle (<30 days) 0.65 (0.43–0.97)
Infertility therapy 1.89 (1.07–3.33) 1.78 (1.00–3.15)
Familial history of
Premature CVD 0.64 (0.73–1.65)
Hypertension 1.10 (0.74–1.63)
Diabetes mellitus 2.58 (1.75–3.79) 2.62 (1.66–415)
Dyslipidemia 1.39 (0.93–2.07)
Stroke 1.18 (0.74–1.90)
Angina pectoris 1.38 (0.84–2.27)
Myocardial infarction 0.45 (0.17–1.22) 0.35 (0.13–0.94)
* Adjusted by age at the pregnancy, the order of pregnancy compared to the first one, menarche 12 years,
menstrual regularity (<4 days), menstrual cycle (<30 days), history of infertility therapy, history of oral
contraceptive pill, familial history of premature CVD, hypertension, diabetes mellitus, dyslipidemia, stroke,
angina pectoris, and myocardial infarction.
CVD = cardiovascular disease; GHD = gestational hypertensive disease; GDM = gestational diabetes
mellitus; OR = odds ratio.
doi:10.1371/journal.pone.0167528.t005
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FHpCVD, FHH, and family history of stroke were closely related to GHD at each pregnancy
in univariable analyses. In multivariable analysis, age, the order of pregnancy, and FHpCVD
were risk factors. Interestingly, age at pregnancy was not a risk factor in a univariable analysis,
whereas it was a risk factor for the occurrence of GHD in the multivariable analysis.
The age at the pregnancy, a longer menstrual cycle (>30 days), history of infertility therapy,
and FHDM were risk factors for GDM in univariable analysis. In GDM analyses, the order of
pregnancy was not a risk factor for the occurrence of GDM at each pregnancy. In multivariable
analysis, age at the pregnancy, history of infertility therapy, FHDM, and family history of myo-
cardial infarction were significantly associated with the occurrence of GDM.
Pregnancy outcome after GHD or GDM at each parity
The occurrence of GHD or GDM was associated with different pregnancy outcomes at each
pregnancy (Table 6). Pregnancies affected by GHD had higher rates of preterm birth and
cesarean section, lower birth weight, greater postpregnancy weight gain, and shorter breast-
feeding duration than pregnancies without GHD. Pregnancies affected by GDM had higher
rates of full-term birth, cesarean section, higher birth weight, greater post-pregnancy weight
gain, and longer breastfeeding duration than those without GDM.
Discussion
Using the database of an online survey recruiting registered nurses, we found that familial his-
tory of cardiovascular diseases is a risk factor for GHD or GDM. FHpCVD was an important
risk factor for GHD in individual women or at any pregnancy including repeated pregnancies.
Table 6. Pregnancy outcome after GHD or GDM at each parity (total 6,685 parity).
Total (n = 6,685) GHD (+) (n = 280) GHD (-) (n = 6,405)) p GDM (+) (n = 140) GDM (-) (n = 6,545) p
Pregnancy duration < 0.001 0.002
21–35 wk 450 (5.1%) 47 (16.8%) 403 (6.3%) 9 (6.4%) 441 (6.7%)
36–41 wk 5,697 (64.9%) 233 (83.2%) 5,464 (85.3%) 131 (93.6%) 5,566 (85.0%)
42 wk 538 (6.1%) 0 (0%) 538 (8.4%) 0 (0%) 538 (8.2%)
Delivery method < 0.001 <0.001
Vaginal delivery 3,889 (64.0%) 132 (47.7%) 3,757 (64.7%) 60 (43.5%) 3,829 (64.4%)
Induced vaginal delivery 360 (5.9%) 24 (8.7%) 336 (5.8%) 7 (5.1%) 353 (5.9%)
Cesarean section 1,832 (30.1%) 121 (43.7%) 1,711 (29.5%) 71 (51.4%) 1,761 (29.6%)
Birth weight <0.001 <0.001
< 2.5 kg 279 (4.5%) 54 (19.3%) 225 (3.8%) 9 (6.4%) 270 (4.5%)
2.5–3.5 kg 4,213 (68.5%) 170 (60.7%) 4,043 (68.9%) 67 (47.9%) 4,146 (69%)
3.5–4.5 kg 1,628 (26.5%) 53 (18.9%) 1,575 (26.8%) 61 (43.6%) 1,567 (26.1%)
>4.5 kg 27 (0.4%) 3 (1.1%) 24 (0.4%) 3 (2.1%) 24 (0.4%)
Postpregnancy weight gain 0.012 0.047
2 kg 2,323 (34.7%) 72 (25.7%) 2,251 (35.1%) 42 (30.0%) 2,281 (34.9%)
3–5 kg 1,980 (29.6%) 91 (32.5%) 1,889 (29.5%) 33 (23.6%) 1,947 (29.7%)
6–10 kg 1,630 (24.4%) 82 (29.3%) 1,548 (24.2%) 42 (30.0%) 1,588 (24.3%)
11 kg 752 (11.2%) 35 (12.5%) 717 (11.2%) 23 (16.4%) 729 (11.1%)
Breastfeeding duration 0.070 0.028
1 months 2,327 (37.9%) 112 (40.0%) 2,215 (37.8%) 37 (26.4%) 2,290 (38.1%)
2–3 months 2,080 (33.8%) 91 (32.5%) 1,989 (33.9%) 53 (37.9%) 2,027 (33.7%)
4–11 months 1,166 (19.0%) 62 (22.1%) 1,104 (18.8%) 36 (25.7%) 1,130 (18.8%)
12 months 574 (9.3%) 15 (5.4%) 559 (9.5%) 14 (10.0%) 560 (9.3%)
doi:10.1371/journal.pone.0167528.t006
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At the same time, FHDM was a risk factor for GDM in individual pregnant women or at any
pregnancy.
The advantage of nurse studies
Health professionals, and particularly nurses, have often been selected as study populations for
large epidemiological surveys because of their high response rates and high accuracy rates in
completing questionnaires.[19, 20] Many investigators have explored associations between
cardiovascular risk factors and diseases using the database from the Nurses’ Health Study.[20–
22] However, many early CVD prevention trials did not focus on specifically on women and
did not include a full range of cardiovascular variables that are specific to women. The investi-
gation of women-specific risk factors using a large survey of nurses is valuable to amassing a
more detailed range of evidence to develop recommendations that address specific consider-
ations of women that current guidelines lack.[23]
GHD and its risk factors
GHD was reported to occur in 5.22% of all pregnancies in a recent study,[4] which is consis-
tent with the prevalence of GHD (6.3%) in the present study. Known GHD risk factors include
twin pregnancy, age>35 years, overweight and obesity, primiparity, hypertension, diabetes
and FHH. The association of hypertensive disorders of pregnancy with higher offspring blood
pressure strongly suggests a genetic link of the diseases.[15] In the present study, we found a
significant association between GHD and FHpCVD after multivariable adjustment, whereas
FHH lost significance after adjustment. The reason underlying our finding that age at preg-
nancy was not a risk factor for the occurrence of a GHD in univariable analysis whereas it was
a risk factor in multivariable analysis is that GHD occurred mostly at the first pregnancy, and
the effect of order of pregnancy was large. Therefore, the effect of age at pregnancy was
obscured in univariable analysis. It is evidence that the older a pregnant woman is, the more
frequently GHD occurred.
GDM and its risk factors
The prevalence of GDM varies among populations, similar to the variation of type 2 diabetes,
with recent prevalence estimates ranging from 2.8% of pregnant women in Washington, DC,
to 18.9% in India and 22% in Sardinia, Italy.[24] There is evidence that old age, obesity, parity,
smoking, and family history are risk factors for GDM.[25] Using a computerized database of
almost one million births in Australia, researchers also identified old maternal age as well as
low socioeconomic position and south Asian ethnicity as important correlates of GDM.[1] We
found that old age and FHDM were risk factors for GDM, but parity was not. GDM incidence
was sustained over successive pregnancies in contrast to GHD.
Poor pregnancy outcome: a future risk of cardiovascular disease
In the present study, the subjects who experienced GHD or GDM showed poor pregnancy
outcomes such as higher rates of delivering a baby with lower birth weight, preterm delivery,
and cesarean section. Pregnancy complications are known to be associated with maternal risk
of ischemic heart disease-related hospital admission or death in the future.[5] Therefore, com-
mon genetic factors might link family history, gestational disease, and future ischemic heart
diseases in the women.
FHpCVD, which was a particularly strong risk factor of GHD in the present study, is a well-
known risk factor of coronary heart disease.[18] Therefore, women should be screened for
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FHpCVD, and then those with a positive FHpCVD and gestational problems should be prop-
erly managed to prevent future events. Population-wide studies are also necessary to under-
stand the women-specific risks of CVD, because individual trials including both sexes are
likely insufficient to capture and analyze the risks of CVD specific to women such as gesta-
tional complications.[26] Understanding sex-based disparities in CVD risks must become an
integral strategy to improve cardiovascular outcomes among women and thus reduce the
global burden of CVD.
Limitation
We used a self-reporting questionnaire to assess the association of GHD or GDM with family
history. Self-reporting is a valuable epidemiologic tool, but it is known to require additional
documentation when the disease is diagnostically complex, for example in myocardial infarc-
tion or stroke.[27] We asked the subjects with the following questions: “For pregnancies lasting
20+ weeks, 1) did you have gestational diabetes? 2) did you have gestational hypertension? 3)
did you have pre-eclampsia?”. Therefore, diagnosis is largely dependent on the subject’s
knowledge of the definition without clear diagnostic criteria. Therefore, this study has a poten-
tial bias related to the diagnostic confirmation of the diseases, although we validated several
responses from the self-report by off-line interviews and measurements.
This is a retrospective study, which is also affected by recall and selection bias. However, we
believe this study to be reliable because several well-established risk factors reported by previous
studies were also strong predictors of GHD, GDM, or pregnancy outcomes in the present
study, and the subjects were all volunteer registered nurses with an interest in the present study.
All the risk factors were assessed retrospectively and we did obtain any information about
whether family history occurred before the GHD or GDM. Therefore, our analyses for risk fac-
tors for GHD or GDM may have residual confounding.
Conclusions
Family history of cardiovascular risk factors was strongly associated with gestational medical
disorders such as GHD and GDM in the Korean Nurses’ Survey. Although current guidelines
do not recommend the routine evaluation of familial history of cardiovascular risk factors on
prenatal testing, meticulous history taking can provide information regarding risks for GHD
and GDM.
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